• Healthcare Policy Pop Podcast
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • State Actions & Resources
    • Legislative Positions
    • Positions
    • Policy Supported
  • Take Action
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • State Actions & Resources
    • Legislative Positions
    • Positions
    • Policy Supported
  • Take Action
  • Donate

Tag: ALS

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Amyotrophic Lateral Sclerosis (ALS)

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Amyotrophic Lateral Sclerosis (ALS)

Jun 23, 2022 | Featured, ICER

On June 14, 2022, ICER released its draft evidence report, “AMX0035 and Oral Edaravone for Amyotrophic Lateral Sclerosis.” This document provides a framework for considering which aspects of two potential treatments for Amyotrophic Lateral Sclerosis (ALS) are...
Read more
Updates from the Frontlines of Medical Research – Season 3 | Episode 18

Updates from the Frontlines of Medical Research – Season 3 | Episode 18

May 9, 2022 | Featured, Podcast

On this episode of the podcast, Terry and Bob discuss the latest medical research into ALS in conjunction with ALS Awareness Month. Dr. Sharon Hesterlee, the Chief Research Officer at the Muscular Dystrophy Association, joins the show to give the big picture on ALS...
Read more

Categories

  • Access
  • Advocacy
  • California
  • Coalitions
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Update on Texas House Bill 999
  • PFPA Member Update – May 22, 2023
  • New Court Ruling May Restore Cost-sharing Barriers to Disease Prevention
  • Patients Rising Now Sends Letter of Support on PBM Bill
  • Patients Rising Now Signs onto Medigap Access Legislation

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now